OrbiMed Advisors »

Corbus Pharmaceuticals Hldgs shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $19M 913k 20.63

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Sinovac Biotech SHS (SVA)
Eli Lilly & Co. (LLY)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Enliven Therapeutics (ELVN)
Biogen Idec (BIIB)
Merck & Co (MRK)
Tenet Healthcare Corp Com New (THC)
Sarepta Therapeutics (SRPT)
Stryker Corporation (SYK)
Silverback Therapeutics (SPRY)
Argenx Se Sponsored Adr (ARGX)
UnitedHealth (UNH)
Q32 Bio (QTTB)

View all positions for OrbiMed Advisors

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
Octagon Capital Advisors
OrbiMed Advisors
BlackRock
BlackRock
Ikarian Capital
Tang Capital Management
Vanguard Group
State Street Corporation
T. Rowe Price Associates
Susquehanna International
Morgan Stanley
Geode Capital Management
Sio Capital Management
Schonfeld Strategic Advisors

View all funds holding Corbus Pharmaceuticals Hldgs